Royalty Pharma Announces Additional $510 Million Acquisition of Interest in Tecfidera and Fumaderm

New York, NY - January 6, 2014 – Royalty Pharma announced today that it has acquired an additional interest in the earn-out payable to the former shareholders of Fumapharm AG for $510 million in cash.

© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.